DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, December 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,379 followers.

New article: DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD? https://t.co/uzfriCuNK9 #MMSM #MultipleMyeloma #hematology

DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD? #lymphoma #lymsm https://t.co/v2eOuOXy31

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.